TBT Pharma

Pathogenesis Based Therapies

At TBT we treat the cause, not the symptom, by developing targeted therapeutic solutions geared at the underlying pathology.  We are a clinical stage dermatology company dedicated to developing and commercializing products to benefit the lives of patients afflicted by psoriasis, orphan diseases, and other inflammatory skin conditions.  We do this by taking advantage of recent discoveries about skin and exploiting them by re-purposing oral and intravenous generic and off-patent compounds for topical use, improving outcomes and patient satisfaction while reducing costs.
TBT-101
targets
  • Psoriasis

  • Keloids

  • Alopecia Areata

  • Inflammatory skin conditions

TBT-102
targets

 

  • Deep Wrinkles

  • Skin Thinning

  • Skin Enhancement 

 

WHAT WE DO